Heparin elimination following continuous infusion during intra‐aortic balloon counterpulsation
Authors:
- 1 January 1985
- journal article
- research article
- Published by Wiley in Catheterization and Cardiovascular Diagnosis
- Vol. 11 (4) , 389-392
Abstract
The decline of the activated partial thromboplastin time (APTT) following discontinuation of heparin infusion was measured in six intra‐aortic balloon pump (IABP) patients. The heparin infusion requirement was determined for eight other IABP patients during stable therapeutic anticoagulation. Following discontinuation of infusion, APTT declined with a relatively constant half‐life (t1/2 of 2.4 ± 0.08 hr, suggesting elimination by first‐order kinetics. In comparison, the t1/2 following single bolus doses has been shown to be markedly dose dependent, increasing from 30 min at low doses to 2 hr at very high doses. The heparin requirement for IABP patients was found to be 16 ± 2.5 U/kg/hr, similar to that reported for other clinical situations. The t1/2 of the APTT following discontinuation of heparin infusion can be used to time invasive procedures that would best be done with normal hemostasis.Keywords
This publication has 11 references indexed in Scilit:
- Effects of Intracoronary Streptokinase and Intracoronary Nitroglycerin Infusion on Coronary Angiographic Patterns and Mortality in Patients with Acute Myocardial InfarctionNew England Journal of Medicine, 1984
- Mechanisms contributing to precipitation of unstable angina and acute myocardial infarction: Implications regarding therapyThe American Journal of Cardiology, 1984
- Identification of patients at high risk for complications of intraaortic balloon counterpulsation: A multivariate risk factor analysisThe American Journal of Cardiology, 1984
- Guidelines for effective and safe percutaneous intraaortic balloon pump insertion and removalThe American Journal of Cardiology, 1981
- Heparin kinetics: Variables related to disposition and dosageClinical Pharmacology & Therapeutics, 1981
- Pharmacokinetic modeling of heparin and its clinical implicationsJournal of Pharmacokinetics and Biopharmaceutics, 1979
- Continuous Heparin Infusion RequirementsJAMA, 1979
- The biologic half‐life of heparinClinical Pharmacology & Therapeutics, 1979
- Heparin Pharmacokinetics: Increased Requirements in Pulmonary EmbolismBritish Journal of Haematology, 1978
- Heparin therapy during extracorporeal circulationThe Journal of Thoracic and Cardiovascular Surgery, 1975